NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 324 filers reported holding NATERA INC in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,112,949 | -13.5% | 92,948 | -4.9% | 0.17% | -9.0% |
| Q2 2023 | $4,756,564 | +58.6% | 97,751 | +32.6% | 0.19% | +85.3% |
| Q1 2022 | $3,000,000 | -31.7% | 73,738 | +56.7% | 0.10% | -20.3% |
| Q4 2021 | $4,394,000 | -6.3% | 47,053 | +11.8% | 0.13% | -12.3% |
| Q3 2021 | $4,689,000 | -6.3% | 42,073 | -4.6% | 0.15% | -5.2% |
| Q2 2021 | $5,004,000 | +11.8% | 44,079 | +0.0% | 0.15% | +3.4% |
| Q1 2021 | $4,476,000 | -91.6% | 44,077 | -91.7% | 0.15% | -92.0% |
| Q4 2020 | $53,097,000 | +33.2% | 533,530 | -3.3% | 1.86% | +5.2% |
| Q3 2020 | $39,867,000 | +54.1% | 551,868 | +6.4% | 1.77% | +42.0% |
| Q2 2020 | $25,865,000 | +67.7% | 518,753 | +0.4% | 1.24% | +24.5% |
| Q1 2020 | $15,423,000 | +11.0% | 516,525 | +25.3% | 1.00% | +53.0% |
| Q4 2019 | $13,889,000 | +6.2% | 412,267 | +3.4% | 0.65% | -3.4% |
| Q3 2019 | $13,083,000 | – | 398,870 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |